James Halstead PLC (The "Company")
Total Voting Rights and application for listing
James Halsted plc (AIM: JHD) confirms, pursuant to the authority granted to the Company at its Annual General Meeting on 18th November 2021, that on 14th January 2022 it issued 208,372,026 ordinary shares of 5p each ("Ordinary Shares") by means of a bonus issue. One new Ordinary Share was issued for every existing Ordinary Share held on the register as at the close of business on the 13th January 2022. The new Ordinary Shares were admitted to trading on AIM on the date of issue.
Following this issue of equity, James Halstead's capital consists of:
· 416,744,052 ordinary shares of 5p each with voting rights;
· 200,000 5.5% cumulative preference shares with no voting rights (except in the case that payment of a dividend is over six months in arrears); and
· 16,042,530 'B' shares of 1p each with no voting rights.
James Halstead does not hold any ordinary shares in Treasury.
Therefore, the total number of voting rights in James Halstead will be 416,744,052.
The above figure of 416,744,052 may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, James Halstead under the FCA's Disclosure Guidance and Transparency Rules.
Application has been made for 1,500,000 new Ordinary Shares to be admitted to trading on AIM under the Company's Block Listing in relation to the James Halstead Group Share Option Plan (1998). The new Ordinary Shares will rank pari passu with the Ordinary Shares then in issue. Admission is expected on 24 January 2022.
For further information please contact: |
|
James Halstead plcDavid Fletcher, Company Secretary |
Telephone 0161 767 2500 |
Hudson Sandler Nick Lyon Nick Moore |
Telephone: 020 7796 4133 |
Panmure Gordon (Nominated adviser & broker) Dominic Morley |
Telephone: 020 7886 2500 |
WH Ireland (Joint Broker) Ben Thorne
|
Telephone: 020 7220 1666 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.